Israel Englander Verona Pharma PLC Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Verona Pharma PLC stock. As of the latest transaction made, Millennium Management LLC holds 527,640 shares of VRNA stock, worth $20.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

527,640

Previous 504,073 4.68%

Holding current value

$20.4 Million

Previous $8.11 Million 5.93%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$11.48 - $17.02 $270,549 - $401,110	23,567 Added 4.68%	527,640 $7.63 Million
Q1 2024 May 15, 2024	BUY	$15.3 - $20.24 $1.85 Million - $2.44 Million	120,722 Added 31.49%	504,073 $8.11 Million
Q4 2023 Feb 14, 2024	SELL	$11.94 - $20.47 $1.79 Million - $3.07 Million	-150,133 Reduced 28.14%	383,351 $7.62 Million
Q2 2023 Aug 14, 2023	SELL	$19.41 - $23.43 $335,365 - $404,823	-17,278 Reduced 3.14%	533,484 $11.3 Million
Q1 2023 May 15, 2023	BUY	$18.06 - $25.27 $4.27 Million - $5.98 Million	236,709 Added 75.37%	550,762 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$9.84 - $26.13 $2.31 Million - $6.13 Million	234,713 Added 295.83%	314,053 $8.21 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $328,467 - $1.08 Million	79,340 New	79,340 $811,000
Q2 2022 Aug 15, 2022	SELL	$3.55 - $5.06 $95,136 - $135,602	-26,799 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.82 - $6.98 $52,200 - $75,593	10,830 Added 67.82%	26,799 $134,000
Q4 2021 Feb 14, 2022	BUY	$3.91 - $7.08 $4,625 - $8,375	1,183 Added 8.0%	15,969 $107,000
Q3 2021 Nov 15, 2021	BUY	$5.29 - $6.35 $78,217 - $93,891	14,786 New	14,786 $81,000
Q4 2020 Feb 16, 2021	SELL	$5.51 - $8.11 $60,290 - $88,739	-10,942 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $48,691 - $111,608	10,942 New	10,942 $68,000

Others Institutions Holding VRNA

# of Institutions

151

Shares Held

65.8M

Call Options Held

495K

Put Options Held

486K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.35B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account